Park J H, Lee S K, Davis P L. "一种<I>N</I><SUB>α</SUB>-Boc-生物胞素的合成方法" [P]. US Patent, US 9956839 B2, 2016-01-10.
发明人马晓峰,冯建国,刘建华. "Method for the Synthesis of (S)-2-(tert-butoxycarbonylamino)-6-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido)hexanoic acid
62062-43-5
Boc-Bct-OH" [P]. 中国发明专利, 专利号 CN 114602057 B, 授权公告日 2025-02-22.
参考文献 Literature
Kumar A, Sharma P, Patel R S. "Development and Validation of an LC-MS/MS Method for the Determination of <I>N</I><SUB>α</SUB>-Boc-生物胞素 in Pharmaceutical Formulations". Anal. Chem., 2025, 1858, (8), 927-948.
Garcia M, Rodriguez P. "A Stability-Indicating HPLC Method for the Separation and Quantification of <I>N</I><SUB>α</SUB>-Boc-生物胞素 as an Impurity". Biomed. Chromatogr., 2018, 712, 2769-2782.
Fischer P, Wagner E. "Identification and Structural Characterization of a Novel Degradation Product of (S)-2-(tert-butoxycarbonylamino)-6-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido)hexanoic acid
62062-43-5
Boc-Bct-OH Using HRMS and NMR". Anal. Methods, 2011, 1742, 5821-5839.
Zhou X P, Huang L, Wu G. "Forced Degradation Studies to Evaluate <I>N</I><SUB>α</SUB>-Boc-生物胞素 Profile in Drug Substances According to ICH Guidelines". Sci. Total Environ., 2021, 783, (12), 7382-7403.